34 Results

People

  1. Panageas
    Panageas
  2. De Angelis
    De Angelis
  3. Reiner
    Reiner
  4. Abrey
    Abrey
  5. Postow
    Postow
  6. Chapman
    Chapman
  7. Iwamoto
    Iwamoto
  8. Lassman
    Lassman
  9. Rosenblum
    Rosenblum
  10. Tabar
    Tabar

Groups

  1. Biostatistics Service (34)
  2. Epidemiology and Biostatistics (34)
  3. Population Sciences Research Program (34)
  4. Tow Center for Developmental Oncology (TCDO) (17)
  5. Department of Medicine (13)
  6. Survivorship Research (12)
  7. GSK Faculty (11)
  8. Solid Tumor Oncology Division (11)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)
  10. Melanoma and Immunotherapeutics Service (9)
  1. "retrospective study"
  2. "Katherine Panageas"
Formats
  1. Journal Article (33)
  2. Review (1)
Groups
  1. Biostatistics Service (34)
  2. Epidemiology and Biostatistics (34)
  3. Population Sciences Research Program (34)
  4. Tow Center for Developmental Oncology (TCDO) (17)
  5. Department of Medicine (13)
  6. Survivorship Research (12)

More Groups

People
  1. Katherine Panageas (34)
  2. Lisa De Angelis (11)
  3. Anne Reiner (10)
  4. Lauren Abrey (7)
  5. Michael Postow (6)
  6. Paul Chapman (6)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (3)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Journal of Neuro-Oncology (4)
  2. Neuro-Oncology (4)
  3. Cancer (3)
  4. Journal of Clinical Oncology (3)
  5. The Oncologist (3)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. Oxford University Press (9)
  2. Springer (6)
  3. Wiley Blackwell (6)
  4. American Society of Clinical Oncology (3)
  5. American Association for Cancer Research (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (34)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Journal Article

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Thomas, T. M.; Nicklin, P. J.; Choi, Y.; Skakodub, A.; Malani, R.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Melanoma-specific clinical outcomes of inpatient immune checkpoint blockade treatment
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Park, V.; Postow, M. A.
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Symptoms, surgical events, and length of stay of surgical oncology outpatients
    Journal Article

    Bloom, L.; Mazzella, A.; Flynn, J.; Panageas, K.
    Journal of PeriAnesthesia Nursing (2022)

    Fulltext@MSK | Save
  • Cerebrospinal fluid diversion for leptomeningeal metastasis: Palliative, procedural and oncologic outcomes
    Journal Article

    Bander, E. D.; Yuan, M.; Reiner, A. S.; Garton, A. L. A.; Panageas, K. S.; Brennan, C. W.; Tabar, V.; Moss, N. S.
    Journal of Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies
    Journal Article

    Bander, E. D.; Yuan, M.; Carnevale, J. A.; Reiner, A. S.; Panageas, K. S.; Postow, M. A.; Tabar, V.; Moss, N. S.
    Cancer (2021)

    Fulltext@MSK | Save
  • Durable 5-year local control for resected brain metastases with early adjuvant SRS: The effect of timing on intended-field control
    Journal Article

    Bander, E. D.; Yuan, M.; Reiner, A. S.; Panageas, K. S.; Ballangrud, Å M.; Brennan, C. W.; Beal, K.; Tabar, V.; Moss, N. S.
    Neuro-Oncology Practice (2021)

    Fulltext@MSK | Save
  • Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival
    Journal Article

    Schaff, L. R.; Yan, D.; Thyparambil, S.; Tian, Y.; Cecchi, F.; Rosenblum, M.; Reiner, A. S.; Panageas, K. S.; Hembrough, T.; Lin, A. L.
    Journal of Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma
    Review

    Hovinga, K. E.; McCrea, H. J.; Brennan, C.; Huse, J.; Zheng, J.; Esquenazi, Y.; Panageas, K. S.; Tabar, V.
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save